Nilotinib Capsules

Nilotinib Capsules

Categories : Oncology

Product Packaging : 30 in HDPE

Product Composition : 150mg, 200mg

Nilotinib Capsules are a targeted tyrosine kinase inhibitor (TKI) used primarily in the treatment of chronic myeloid leukemia (CML). It works by selectively inhibiting the BCR-ABL kinase, a key driver of leukemia cell proliferation, thereby helping control disease progression.

Genliva Wellness LLP is a trusted Nilotinib capsule exporter from India, offering high-quality hematology and oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supplies advanced oncology medicines to international distributors, hospitals, and pharmaceutical importers with a strong focus on quality, compliance, and reliability.

Send Message

Nilotinib Capsules are a targeted tyrosine kinase inhibitor (TKI) used primarily in the treatment of chronic myeloid leukemia (CML). It works by selectively inhibiting the BCR-ABL kinase, a key driver of leukemia cell proliferation, thereby helping control disease progression.

Genliva Wellness LLP is a trusted Nilotinib capsule exporter from India, offering high-quality hematology and oncology capsule formulations for export markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supplies advanced oncology medicines to international distributors, hospitals, and pharmaceutical importers with a strong focus on quality, compliance, and reliability.

Nilotinib Capsules are indicated for:

  • Chronic Myeloid Leukemia (CML) – Philadelphia chromosome positive (Ph+)
  • Newly diagnosed or resistant/intolerant CML cases
  • Use in targeted hematology-oncology treatment regimens

whatsapp-app